Bakignot, Jahrizza A.
HRN: 26-36-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
CEFUROXIME 500MG (TAB)
12/21/2024
12/28/2024
PO
500mg
BID X 7 Days
RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes